NCT06561685 2026-02-10
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
Eli Lilly and Company
Phase 1 Recruiting
Eli Lilly and Company
University of Miami
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)